Director, Strategic Account Lead – National - ALNYLAM PHARMACEUTICALS
(2025-01)
- Lead national strategic engagement across top-tier Integrated Delivery Networks (IDNs) and academic medical centers, including Mayo Clinic and Cleveland Clinic, to expand patient access and optimize ATTR-CM care pathways.
- Serve as senior enterprise partner to Trinity Health, building executive-level relationships and advancing cross-functional collaborations spanning access, operations, contracting, and care delivery.
- Designed and executed national commercial and care delivery strategies for AMVUTTRA (ATTR-CM), improving system-level adoption, stakeholder alignment, and patient identification across complex health systems.
- Act as a national thought leader within Strategic Accounts, integrating clinical pathways, EHR analytics, site-of-care strategy, and operational insights into integrated account plans.
Global Resource Management Lead – Chief Marketing Office - PFIZER INC.
(2023-07 - 2024-12)
- Built and led Pfizer's first-ever Global Resource Management function, transforming enterprise marketing operations across brands, regions, and therapeutic areas.
- Secured $159M in approved investment from a $200M proposal through disciplined prioritization, executive engagement, and financial rigor.
- Delivered $41M in cost savings while improving speed, transparency, governance, and ROI across global marketing operations.
US Rare Disease Business Unit Transformation Lead - PFIZER INC.
(2021-12 - 2023-07)
- Directed Bold Move 3.3, Pfizer's flagship transformation initiative for the Rare Disease business, driving organizational agility, innovation, and execution excellence.
- Founded and led the Global 3.3 Ambassador Forum, enabling cross-functional and cross-regional collaboration and accelerating best-practice adoption across global markets.
National Rare Disease Key Account Manager & Field Reimbursement Lead - PFIZER INC.
(2018-11 - 2021-12)
- Played a central role in the launch and national scale of VYNDAMAX, contributing to >$5B in annual revenue and market leadership in ATTR-CM.
- Led the Bold Move FAS/PAC pilot, establishing the blueprint for global access strategy, field reimbursement integration, and health system expansion in ATTR-CM.
- Served as a national subject-matter expert in market access, reimbursement, and enterprise health system engagement for rare disease portfolios.
Regional Business Director – West US, Biosimilars - PFIZER INC.
(2018-04 - 2018-11)
- Designed and executed a regional oncology biosimilars growth strategy, helping position INFLECTRA as a $1B brand.
- Co-created a revised sub-ceiling contracting and IDN engagement model, improving contracting efficiency and accelerating speed to market.
Chief of Staff & Director of Business Management – Rare Disease Oncology, Payer Channel Access & Specialty Access Solutions - PFIZER INC.
(2014-10 - 2018-04)
- Built a national specialty pharmacy and IDN distribution network for Pfizer's oncology portfolio, improving access, reimbursement consistency, and operational execution.
- Developed the account management launch strategy for IBRANCE, supporting its growth into a $5B global brand in metastatic breast cancer.
- Led HUB optimization initiatives with co-promote partner Astellas for XTANDI, enhancing patient experience and reducing access friction.
National Lead – US Oncology & Hematology Key Account Management - PFIZER INC.
(2012-08 - 2014-10)
- Led Pfizer's entry into hematology, driving early adoption and utilization of BOSULIF.
- Designed the national launch playbook, go-to-market strategy, and standalone hematology sales force model, establishing a new organizational capability within Pfizer Oncology.
Oncology Account Manager - PFIZER INC.
(2010-05 - 2012-08)
- Launched XALKORI for NSCLC, delivering precision-medicine excellence in a highly competitive oncology market.
- Selected as Pfizer's first Oncology Key Account Manager in the Southeast region.
- Earned national recognition for performance, leadership, and customer impact.
District Manager - PFIZER INC.
(2001-12 - 2010-05)
- Led a consistently top-decile performing district, ranking in the top 10% nationally across multiple years.
- Built and developed high-performing teams; promoted multiple individuals into leadership roles.
- Successfully launched flagship brands including CELEBREX, SPIRIVA, and CHANTIX.
